期刊文献+

结核分支杆菌临床分离株耐药性调查与耐多药结核病流行特点探讨 被引量:8

A survey of the drug resistance in Clinical isolates of Mycobacterium tuberculosis and the epidemic trend of multidrug-resistant tuberculosis
下载PDF
导出
摘要 目的调查结核临床分离株的耐药性,探讨多耐药结核病(MDR-TB)流行特点。方法采用匡氏琼脂培养基按比例法测定287株结核菌(56株来自初治病例)对8种抗痨药物的耐药性。结果初治病例菌株和复治病例菌株对异烟肼、利福平、链霉素、吡嗪酰胺高度耐药率分别为1.8%、3.6%、17.9%、0%和74.9%、58.0%、68.4%、32.0%,差异均极显著(P<0.001)。复治病例MDR株占63.2%,广泛耐药(XDR)株占10%,15.8%的MDR株为XDR株;初治病例无XDR株感染,MDR株占1.8%,极显著低于复治病例MDR株比率(P<0.001)。结论住院结核病患者MDR株和XDR株感染率高,且主要由获得性耐药产生。DOTS策略仍是我国耐药结核病防治重点。 Objective To investigate the drug resistance in clinical isolates from the initially treated cases and the relapse cases and to evaluate the prevalent trend in drug-resistant tuberculosis.Methods The susceptibility assays of 8 drugs in 287 clinical isolates of M. tuberculosis (56 strains of those were isolated from initially treated cases ) were performed by pmporation method using Kuangs, agar medium. Results The rate of high resistant strains to isoniazid, rifampin, streptomycin, pyrazinamide were 1.8%, 3.6%, 17.9 %, 0.0%. in initially treated cases and 74.9 %, 58.0%, 68.4%, 32.0%, in relapse cases, respectively, and there were statistic significances between each drug ( P 〈 0.001 ). The mulfidrug-resistance(MDR) strains in relapse cases occurred in a rate of 63.2% and the extensive drug resistance(XDR) strains in a rate of 10%. 18% of MDR strains was XDR strains.No XDR strain was found in initially treated Cases and the rate of MDR strains was 1.8 %. Conclusion A high rates of hospitaliged patients were infected by MDR and XDR Strains of M. tuberculosis and those MDR bacilli were originated in acquired drug resistance. DOT s Should be still the emphasis of measures in prevention and control of drug-resistant tuberculosis.
出处 《中国实验诊断学》 北大核心 2009年第5期569-571,共3页 Chinese Journal of Laboratory Diagnosis
基金 国家自然科学基金资助项目(No.30571403)
关键词 结核病 结核分支杆菌 耐药性 耐多药 广泛耐药 tuberculosis Mycobacterium tuberculosis drug resistance Muhidrug-resistance Extensive Drug Resistance
  • 相关文献

参考文献5

  • 1W H O The globe MDR&XDR response,2007 - 2008.
  • 2匡铁吉,董梅,等.匡氏琼脂培养基用于痰结核菌直接药敏试验的效果研究[J].中国检验医学与临床,2002,3(2):54-56. 被引量:17
  • 3W H O Anti-tuberculosis drug resistance in the world. Report No 2. Prevalance and trends. Geneva: W H O,2000.
  • 4Sugaware I, Otomo k, Yamada H, et al. rFne molecular epidemiology of ethambutol-resistant Mycobacterium tuberculosis in Henan Province, China [J] .Jpn J Infet Dis,2005,58(6) :393.
  • 5W H O Tuberculosis XDR-TB,the facts,2007.

共引文献16

同被引文献73

引证文献8

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部